MarkNtel Advisors has just published a new research report titled "Non-Small Cell Lung Cancer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027". This study provides an extensive analysis of market drivers, segmentation, growth opportunities, trends, and competitive landscape, aiming to provide insights into current and future market scenarios.
What insights and analysis does the report provide on the Non-Small Cell Lung Cancer market from 2022 to 2027?
The Global Non-Small Cell Lung Cancer (NSCLC) Market is projected to grow at a CAGR of around 11.2% during the forecast period, i.e., 2022-27.
“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”
To obtain further details about this report, please request a sample copy – https://www.marknteladvisors.com/query/request-sample/non-small-cell-lung-cancer-market.html
Non-Small Cell Lung Cancer Market by Segments
By Diagnosis
- Blood & Urine Tests
- Imaging
- Biopsy
- Sputum Cytology
- Bronchoscopy
By Cancer Type
- Squamous Cell Carcinoma (SCC)
- Large Cell Carcinoma (LCC)
- Adenocarcinoma
By Treatment
- Surgery
- Chemotherapy
- Immunotherapy
- Immune Checkpoint Inhibitors
- PD-1/PD-L1 Inhibitors
- CTLA-4 Inhibitor
- Radiation Therapy
- External Beam Radiation Therapy
- Brachytherapy (Internal Radiation Therapy)
- Radiofrequency Ablation (RFA)
- Targeted Therapy
By End-User
- Hospitals
- Cancer Centers
- Others (Ambulatory Surgery Centers, etc.)
A comprehensive report on the Non-Small Cell Lung Cancer Market is available now- https://www.marknteladvisors.com/research-library/non-small-cell-lung-cancer-market.html
Non-Small Cell Lung Cancer Market Report Segment by Regions
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Note - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Who are the key players in the Non-Small Cell Lung Cancer Market?
- Allergan (AbbVie)
- AstraZeneca PLC
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eisai Co., Ltd.
- Eli Lilly and Company
- GlaxoSmithKline PLC
- Hoffmann-La Roche AG
- Merck & Co., Inc.
- Novartis International AG
- Pfizer Inc.
- Sanofi S.A.
- Others
Questions Addressed in this Study
- What factors are driving the Non-Small Cell Lung Cancer Market growth?
- How is the Non-Small Cell Lung Cancer Market expected to grow over the next five years?
- What are the key insights into the current trends in the Non-Small Cell Lung Cancer Market?
- What is the current size of the Non-Small Cell Lung Cancer Market, and how is it projected to change in the future?
- What is the future outlook for the Non-Small Cell Lung Cancer Market in terms of technological advancements and market expansion?
Request Customization – https://www.marknteladvisors.com/query/request-customization/non-small-cell-lung-cancer-market.html
Why choose MarkNtel?
MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.
Contact Us –
Call: ? +1 628 895 8081 +91 120 4278433
Email: ? sales@marknteladvisors.com
Visit to know more: ? https://www.marknteladvisors.com/
